Indivior plc
INDV 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
INDV 近期報酬表現
-2.48%
Indivior plc
-0.03%
同產業平均
0.13%
S&P500
與 INDV 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
VTYX | Ventyx biosciences inc | - | 3 分 | 2 分 | 1 分 | 1 分 | |
IOVA | Iovance biotherapeutics inc | 3 分 | 5 分 | 3 分 | 2 分 | 1 分 | |
MRVI | Maravai lifesciences holdings inc | 3 分 | 5 分 | 3 分 | 2 分 | 1 分 | |
DARE | Dare bioscience inc | 3 分 | 2 分 | 1 分 | 1 分 | 1 分 | |
AGIO | Agios pharmaceuticals inc | 3 分 | 4 分 | 4 分 | 3 分 | 1 分 |
- VTYX Ventyx biosciences inc價值 -趨勢 3 分波段 2 分籌碼 1 分股利 1 分查看更多
INDV 公司資訊
Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its Sublocade, Subutex, and Suboxone are used for the treatment of opioid use disorder (OUD). Perseris is used for the treatment of Schizophrenia. The Company's pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine Sublingual and Naloxone Film, and Buprenorphine and Naloxone Sublingual Tablet. Its pipeline also includes the Orexin-1 Receptor Antagonist Program.